共 11 条
- [2] THE EFFECTS OF A NEW ANTIHYPERTENSIVE AGENT, SGB-1534 ON THE CARDIOVASCULAR HEMODYNAMICS OF THE DOG JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P174 - P174
- [3] EFFECTS OF A NEW ANTIHYPERTENSIVE AGENT, SGB-1534 ON PLATELET-AGGREGATION JAPANESE JOURNAL OF PHARMACOLOGY, 1985, 39 : P343 - P343
- [4] EFFECTS OF A NEW ANTIHYPERTENSIVE AGENT, SGB-1534, ON RAT PLATELET-AGGREGATION JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 42 (04): : 493 - 500
- [5] POTENT ALPHA-ADRENOCEPTOR BLOCKING ACTION OF SGB-1534, A NEW QUINAZOLINE ANTIHYPERTENSIVE AGENT INVITRO EXPERIMENTS GENERAL PHARMACOLOGY, 1986, 17 (02): : 143 - 149
- [6] ALPHA-BLOCKING POTENCIES OF ANTIHYPERTENSIVE AGENTS (PRAZOSIN, TERAZOSIN, BUNAZOSIN, SGB-1534 AND KETANSERIN) HAVING WITH QUINAZOLINE OR QUINAZOLINEDIONE AS ASSESSED BY RADIOLIGAND BINDING ASSAY-METHODS IN RAT-BRAIN JOURNAL OF PHARMACOBIO-DYNAMICS, 1989, 12 (03): : 170 - 174
- [8] BETA-BLOCKING POTENCY AND SELECTIVITY OF BOPINDOLOL AND ITS 2 METABOLITES FOR BETA-1-ADRENERGIC AND BETA-2-ADRENERGIC RECEPTORS AS ASSESSED BY RADIOLIGAND BINDING ASSAY JOURNAL OF PHARMACOBIO-DYNAMICS, 1991, 14 (05): : 250 - 255
- [9] BETA-RECEPTOR BLOCKING POTENCIES OF THE 3 NEWLY SYNTHESIZED BETA-ADRENERGIC ANTAGONISTS (S-596, K-351, N-696) AS ASSESSED WITH THE RADIOLIGAND BINDING ASSAY-METHOD IN RAT CARDIAC-MUSCLE MEMBRANE TREATED WITH NEURAMINIDASE JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 34 (02): : 249 - 254
- [10] ALPHA-1 AND BETA-ADRENERGIC-RECEPTOR BLOCKING POTENCIES OF BOPINDOLOL AND ITS 2 METABOLITES (18-502 AND 20-785) AS ASSESSED BY RADIOLIGAND BINDING ASSAY-METHODS GENERAL PHARMACOLOGY, 1995, 26 (04): : 743 - 747